Director/PDMR Shareholding
Updated : 13:01
12 April 2022
Oxford Nanopore Technologies plc (the "Company")
Director/PDMR Notification
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
The Company has been notified that, on 12 April 2022, Adrian Hennah, a Non-executive Director of the Company, purchased a total of 14,125 ordinary shares at a price of 355.705p per share.
Name | Number of shares acquired | Price per share (pence) |
Adrian Hennah | 14,125 | 355.705p |
This announcement is made pursuant to the Company's obligations under Article 19 of the UK Market Abuse Regulation.
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
a) | Name | Adrian Hennah | ||||
2 | Reason for the notification | |||||
a) | Position/status | Non-executive Director | ||||
b) | Initial/Amendment notification | Initial notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Oxford Nanopore Technologies PLC | ||||
b) | LEI | 213800IRWQ2Q6M2CDW55 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of £0.0001 each
GB00BP6S8Z30 | ||||
b) | Nature of the transaction | Purchase of shares in the Company | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Aggregated price |
| ||||
e) | Date of the transaction | 12 April 2022 | ||||
f) | Place of the transaction | London Stock Exchange (XLON) |
[ENDS]
Enquiries:
Investors
Media
oxfordnanoporetechnologies@tulchangroup.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.